US Patent 7846441 Treatment with anti-ErbB2 antibodies
Patent 7846441 was granted and assigned to Genentech on December, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+388 characters)
Article
Patent abstract
The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Susan D. Hellmann0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07846441 Treatment with anti-ErbB2 antibodies US Patent 7846441 Treatment with anti-ErbB2 antibodies
Infobox
Patent Number
078464410
Patent Number
78464410
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078464410
Date of Patent
December 7, 2010
0Patent Application Number
092086490
Date Filed
December 10, 1998
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07846441 Treatment with anti-ErbB2 antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07846441
Date of patent
December 7, 2010
Patent application number
09208649
Date Filed
December 10, 1998
Patent primary examiner
Find more entities like US Patent 7846441 Treatment with anti-ErbB2 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
